rs2834167

Variant names:

Your query was ambiguous. Multiple possible variants found:

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000628.5(IL10RB):c.139A>G(p.Lys47Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.275 in 1,613,124 control chromosomes in the GnomAD database, including 66,866 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5821 hom., cov: 32)

Exomes 𝑓: 0.28 ( 61045 hom. )

Consequence

IL10RB
NM_000628.5 missense

Scores

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: 0.677

Variant links:

Genes affected

IL10RB (HGNC:5965): (interleukin 10 receptor subunit beta) The protein encoded by this gene belongs to the cytokine receptor family. It is an accessory chain essential for the active interleukin 10 receptor complex. Coexpression of this and IL10RA proteins has been shown to be required for IL10-induced signal transduction. This gene and three other interferon receptor genes, IFAR2, IFNAR1, and IFNGR2, form a class II cytokine receptor gene cluster located in a small region on chromosome 21. [provided by RefSeq, Jul 2008]

IL10RB links:

IFNAR2-IL10RB (HGNC:):

IFNAR2-IL10RB links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4

Computational evidence support a benign effect (MetaRNN=7.5644255E-4).

BP6

Variant 21-33268483-A-G is Benign according to our data. Variant chr21-33268483-A-G is described in ClinVar as [Benign]. Clinvar id is 16923.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-33268483-A-G is described in Lovd as [Benign].

BA1

GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.552 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
IL10RB	NM_000628.5 link	c.139A>G	p.Lys47Glu	missense_variant	Exon 2 of 7	ENST00000290200.7	NP_000619.3	Q08334

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
IL10RB	ENST00000290200.7 link	c.139A>G	p.Lys47Glu	missense_variant	Exon 2 of 7	1	NM_000628.5	ENSP00000290200.2		Q08334
IFNAR2-IL10RB	ENST00000433395.7 link	c.799A>G	p.Lys267Glu	missense_variant	Exon 8 of 13	5		ENSP00000388223.3		H0Y3Z8

Frequencies

GnomAD3 genomes

AF:

0.254

AC:

38639

AN:

152118

Hom.:

5821

Cov.:

show subpopulations

Gnomad AFR

AF:

0.127

Gnomad AMI

AF:

0.230

Gnomad AMR

AF:

0.385

Gnomad ASJ

AF:

0.283

Gnomad EAS

AF:

0.569

Gnomad SAS

AF:

0.392

Gnomad FIN

AF:

0.324

Gnomad MID

AF:

0.332

Gnomad NFE

AF:

0.256

Gnomad OTH

AF:

0.253

GnomAD2 exomes

AF:

0.330

AC:

83064

AN:

251442

AF XY:

0.330

show subpopulations

Gnomad AFR exome

AF:

0.121

Gnomad AMR exome

AF:

0.502

Gnomad ASJ exome

AF:

0.279

Gnomad EAS exome

AF:

0.569

Gnomad FIN exome

AF:

0.320

Gnomad NFE exome

AF:

0.262

Gnomad OTH exome

AF:

0.320

GnomAD4 exome

AF:

0.278

AC:

405506

AN:

1460888

Hom.:

61045

Cov.:

AF XY:

0.281

AC XY:

204127

AN XY:

726848

show subpopulations

Gnomad4 AFR exome

AF:

0.119

AC:

3985

AN:

33470

Gnomad4 AMR exome

AF:

0.491

AC:

21959

AN:

44720

Gnomad4 ASJ exome

AF:

0.281

AC:

7353

AN:

26128

Gnomad4 EAS exome

AF:

0.555

AC:

22042

AN:

39684

Gnomad4 SAS exome

AF:

0.381

AC:

32889

AN:

86238

Gnomad4 FIN exome

AF:

0.320

AC:

17081

AN:

53418

Gnomad4 NFE exome

AF:

0.253

AC:

280663

AN:

1111130

Gnomad4 Remaining exome

AF:

0.291

AC:

17578

AN:

60350

Heterozygous variant carriers

15791

31581

47372

63162

78953

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Exome Het

Exome Hom

Variant carriers

9722

19444

29166

38888

48610

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.254

AC:

38649

AN:

152236

Hom.:

5821

Cov.:

AF XY:

0.263

AC XY:

19580

AN XY:

74422

show subpopulations

Gnomad4 AFR

AF:

0.126

AC:

0.126365

AN:

0.126365

Gnomad4 AMR

AF:

0.386

AC:

0.385808

AN:

0.385808

Gnomad4 ASJ

AF:

0.283

AC:

0.28341

AN:

0.28341

Gnomad4 EAS

AF:

0.569

AC:

0.569032

AN:

0.569032

Gnomad4 SAS

AF:

0.392

AC:

0.392368

AN:

0.392368

Gnomad4 FIN

AF:

0.324

AC:

0.32389

AN:

0.32389

Gnomad4 NFE

AF:

0.256

AC:

0.255868

AN:

0.255868

Gnomad4 OTH

AF:

0.255

AC:

0.255208

AN:

0.255208

Heterozygous variant carriers

1421

2841

4262

5682

7103

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Genome Het

Genome Hom

Variant carriers

408

816

1224

1632

2040

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.266

Hom.:

26542

Bravo

AF:

0.256

TwinsUK

AF:

0.253

AC:

939

ALSPAC

AF:

0.258

AC:

994

ESP6500AA

AF:

0.131

AC:

576

ESP6500EA

AF:

0.257

AC:

2214

ExAC

AF:

0.319

AC:

38727

Asia WGS

AF:

0.465

AC:

1615

AN:

3478

EpiCase

AF:

0.275

EpiControl

AF:

0.275

ClinVar

Significance: Benign

Submissions summary: Benign:7Other:1

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not specified

Benign:4

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen

Significance:Benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

Genome Diagnostics Laboratory, University Medical Center Utrecht

Significance:Benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

Nov 12, 2023

Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 75% of patients studied by a panel of primary immunodeficiencies. Number of patients: 72. Only high quality variants are reported. -

Mar 28, 2016

Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency, associated with susceptibility to hepatitis -

Inflammatory bowel disease 25

Benign:2

Feb 03, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Mar 06, 2018

Illumina Laboratory Services, Illumina

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided

Benign:1

Breakthrough Genomics, Breakthrough Genomics

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:not provided

- -

Hepatitis B virus, susceptibility to

Other:1

Jun 13, 2006

OMIM

Significance:risk factor

Review Status:no assertion criteria provided

Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Benign

0.081

BayesDel_addAF

Benign

-0.46

BayesDel_noAF

Benign

-0.30

CADD

Benign

DANN

Uncertain

0.99

DEOGEN2

Benign

0.13

Eigen

Benign

-0.067

Eigen_PC

Benign

0.010

FATHMM_MKL

Benign

0.16

LIST_S2

Benign

0.47

MetaRNN

Benign

0.00076

MetaSVM

Benign

-0.87

MutationAssessor

Benign

1.8

PROVEAN

Benign

-1.9

REVEL

Benign

0.10

Sift

Benign

0.084

Sift4G

Benign

0.29

Polyphen

0.58

Vest4

0.043

MPC

0.50

ClinPred

0.015

GERP RS

2.6

Varity_R

0.39

gMVP

0.62

Mutation Taster

=80/20

polymorphism (auto)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

LitVar

Other links and lift over